Development services for minimally invasive glaucoma surgery (MIGS) device

Who already wins at this buyer

Firms with recorded awards from Inven2 AS in this tender’s CPV categories — the incumbents you are bidding against.

Full buyer profile: what Inven2 AS buys and who wins it →

CPV codes

Description

We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimising the stent design using in sil billiard modelling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection moulding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.

Similar tenders

Closest by meaning — across languages, via embeddings.

Source

View the official notice on TED ↗